A combination of sevoflurane postconditioning and albumin increases Bcl-2 expression after transient global cerebral ischemia compared with either sevoflurane postconditioning or albumin alone

Journal of Neurosurgical Anesthesiology

Volumn 25, Issue 1, 2013, Pages 43-50

  Jeon, Young Tae ^a   Hwang, Jung Won ^a   Lim, Young Jin ^a   Kim, Ahn Na ^a   Park, Hee Pyoung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

albumin; apoptosis; cerebral ischemia; neuroprotection; sevoflurane postconditioning

Indexed keywords

ALBUMIN; PROTEIN BCL 2; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; HEMORRHAGIC HYPOTENSION; HIPPOCAMPAL CA1 REGION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT;

ACTINS; ALBUMINS; ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD GAS ANALYSIS; BLOTTING, WESTERN; CA1 REGION, HIPPOCAMPAL; CELL COUNT; DNA FRAGMENTATION; GENE EXPRESSION; GENES, BCL-2; HEMOGLOBINS; IN SITU NICK-END LABELING; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC POSTCONDITIONING; MALE; METHYL ETHERS; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84872378091     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31826ca3bc     Document Type: Article

References (32)

1. Belayev L, Saul I, Huh PW, et al. Neuroprotective effect of highdose albumin therapy against global ischemic brain injury in rats. Brain Res. 1999;845:107-111. (Pubitemid 29472375)
2. Belayev L, Alonso OF, Huh PW, et al. Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J Neurotrauma. 1999;16:445-453. (Pubitemid 29297900)
3. Belayev L, Liu Y, Zhao W, et al. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke. 2001;32: 553-560. (Pubitemid 32155250)
4. Belayev L, Pinard E, Nallet H, et al. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke. 2002;33:1077-1084. (Pubitemid 34293595)
5. Lang JD Jr., Figueroa M, Chumley P, et al. Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology. 2004;100:51-58. (Pubitemid 38031654)
6. Schnitzer JE, Oh P. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem. 1994;269:6072-6082.
7. Tokumura A, Yoshida J, Maruyama T, et al. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. Thromb Res. 1987;46:51-63. (Pubitemid 17068368)
8. Luo Y, Ma D, Ieong E, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology. 2008;109:782-789.
9. Sakai H, Sheng H, Yates RB, et al. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology. 2007;106:92-99; discussion 8-10.
10. Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010;1357: 142-151.
11. Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth. 2010;104:191-200.
12. Smith ML, Bendek G, Dahlgren N, et al. Models for studying longterm recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand. 1984;69:385-401. (Pubitemid 14080982)
13. Nimmagadda A, Park HP, Prado R, et al. Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study. Stroke. 2008;39:198-204.
14. Park HP, Nimmagadda A, DeFazio RA, et al. Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study. Stroke. 2008;39:1556-1562.
15. Conzen PF, Vollmar B, Habazettl H, et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg. 1992;74:79-88.
16. Katz L, Ebmeyer U, Safar P, et al. Outcome model of asphyxia cardiac arrest in rats. J Cereb Blood Flow Metab. 1995;15:1032- 1039.
17. Meybohm P, Gruenewald M, Zacharowski KD, et al. Mild hypothermia alone or in combination with anesthetic post-conditioning reduces expression of inflammatory cytokines in the cerebral cortex of pigs after cardiopulmonary resuscitation. Crit Care. 2010;14:R21-31.
18. Eberspacher E, Eckel B, Engelhard K, et al. Effects of sevoflurane on cognitive deficit, motor function, and histopathology after cerebral ischemia in rats. Acta Anaesthesiol Scand. 2009; 53:774-782.
19. Wong K, Cleland LG, Poznansky MJ. Enhanced anti-inflammatory effect and reduced immunogenicity of bovine liver superoxide dismutase by conjugation with homologous albumin. Agents Actions. 1980;10:231-239. (Pubitemid 10051493)
20. Halliwell B. Albumin - an important extracellular antioxidant? Biochem Pharmacol. 1988;37:569-571.
21. Roche M, Rondeau P, Singh NR, et al. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783-1787.
22. Wilson JX, Gelb AW. Free radicals, antioxidants, and neurologic injury: possible relationship to cerebral protection by anesthetics. J Neurosurg Anesthesiol. 2002;14:66-79. (Pubitemid 34027705)
23. Huh PW, Belayev L, Zhao W, et al. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res. 1998;804:105-113. (Pubitemid 28410484)
24. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40:331-339.
25. Niizuma K, Yoshioka H, Chen H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochem Biophys Acta. 2010;1802:92-99.
26. Pape M, Engelhard K, Eberspacher E, et al. The long-term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg. 2006;103:173-179. (Pubitemid 44036054)
27. Baltanas FC, Weruaga E, Valero J, et al. Albumin attenuates DNA damage in primary-cultured neurons. Neurosci Lett. 2009;450: 23-26.
28. Kawaguchi M, Drummond JC, Cole DJ, et al. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth Analg. 2004;98:798-805. (Pubitemid 38252679)
29. Palesch YY, Hill MD, Ryckborst KJ, et al. The ALIAS Pilot Trial: a dose-Escalation and safety study of albumin therapy for acute ischemic stroke - II: neurologic outcome and efficacy analysis. Stroke. 2006;37:2107-2114. (Pubitemid 44309912)
30. Hill MD, Martin RH, Palesch YY, et al. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke. 2011;42:1621-1625.
31. Elsersy H, Sheng H, Lynch JR, et al. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology. 2004;100:1160-1166. (Pubitemid 38541971)
32. Miura Y, Grocott HP, Bart RD, et al. Differential effects of anesthetic agents on outcome from near-complete but not incomplete global ischemia in the rat. Anesthesiology. 1998;89:391-400. (Pubitemid 28373429)